We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Akershus Early Mobilisation in Stroke Study (AKEMIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00832351
Recruitment Status : Completed
First Posted : January 30, 2009
Last Update Posted : January 1, 2016
South-Eastern Norway Regional Health Authority
Information provided by (Responsible Party):
Antje Sundseth, University Hospital, Akershus

Brief Summary:

Treatment in stroke units compared with treatment in general medical wards reduces the odds of being dead or disabled. Little is known about which components of acute stroke care that is responsible for this benefit.

Early mobilisation is one of the features of stroke unit care. In Scandinavia, any intervention aimed to reduce the time to the first out of bed episode has been focused in order to prevent complications.

However, therapeutic interventions for cerebral revascularisation and a more intensive unit approach for observation may postpone mobilisation. The aim of the present study is to identify whether early mobilisation (< 24 hours after admittance to hospital)reduce disability and mortality compared with mobilisation after 24 hours.

The study is a prospective, randomised controlled study with blinded assessment at the end of follow up. Patients admitted to the Stroke Unit, Akershus University Hospital less than 24 hours after stroke during 2009 - 2011 are screened for recruitment. Patients are randomly assigned to either mobilisation out of bed within 24 hours from admittance to hospital or mobilisation after 24 hours. Except early contra late mobilisation all patients receive standard stroke unit care.

Patients with modified Rankin Scale 0 and 1, patients with a secondary intracerebral hemorrhage, patients receiving thrombolysis or patients requiring palliative care are excluded.

All patients are assessed at admittance, discharge and 3 months poststroke. Investigations at admittance include standard blood sample, CT/MRI scan, EKG and ultrasound of carotid arteries.

Main outcome is mortality and disability 3 months poststroke. Secondary outcome measures are neurological deficits (NIH), morbidity, complications, cognitive function reflected by Mini Mental State Examination and emotional function (Hospital Anxiety and Depression scale) .

Results from this study may add important knowledge about how and when to start mobilisation of patients with acute stroke.

Condition or disease Intervention/treatment
Stroke Procedure: Mobilisation

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 65 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Immediate Mobilisation After Stroke on Mortality, Morbidity and Functional Outcome
Study Start Date : March 2009
Primary Completion Date : May 2010
Study Completion Date : May 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Early mobilisation within 24 hours after admittance to hospital
Procedure: Mobilisation
No Intervention: 2
Mobilisation after 24 but within 48 hours from admittance to hospital

Primary Outcome Measures :
  1. Effect of early mobilisation after stroke (< 24 hours after admittance to hospital) on mortality, morbidity and functional outcome [ Time Frame: 3 month ]

Secondary Outcome Measures :
  1. Neurological deficits [ Time Frame: 3 month ]

  2. Morbidity [ Time Frame: 3 month ]
  3. Complications [ Time Frame: 3 month ]
  4. Cognitive function [ Time Frame: 3 month ]

  5. Emotional function [ Time Frame: 3 month ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients admitted to the Department of Neurology, Akershus University Hospital, with acute stroke (ischemic or hemorrhagic)

Exclusion Criteria:

  • admitted to hospital more than 24 hours after stroke onset
  • mRS 0 and 1
  • mRS 5
  • patients requiring palliative care
  • secondary/traumatic intracerebral hemorrhage
  • pregnancy
  • i.v./i.a. thrombolysis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00832351

Department of Neurology, Akershus University Hospital
Lørenskog, Akershus, Norway, 1478
Sponsors and Collaborators
University Hospital, Akershus
South-Eastern Norway Regional Health Authority
Study Chair: Ole Morten Rønning, MD, PhD Department of Neurology, Akershus University Hospital

Responsible Party: Antje Sundseth, MD, University Hospital, Akershus
ClinicalTrials.gov Identifier: NCT00832351     History of Changes
Other Study ID Numbers: 1.2006.322 (REK)
04/01666-22 (NSD)
First Posted: January 30, 2009    Key Record Dates
Last Update Posted: January 1, 2016
Last Verified: December 2015

Keywords provided by Antje Sundseth, University Hospital, Akershus:
Brain infarction
Intracerebral hemorrhage
Early Mobilisation

Additional relevant MeSH terms:
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases